The purpose of this study is to access the efficacy and safety of LCZ696 compared to
olmesartan in elderly Asian patients for the treatment of hypertension.
Minimum age: 65 Years.
Maximum age: N/A.
Gender(s): Both.
Novartis Investigative Site, Beijing 100044, China
Novartis Investigative Site, Beijing 100020, China
Novartis Investigative Site, Shanghai 200025, China
Novartis Investigative Site, Tianjin 300142, China
Novartis Investigative Site, Hong Kong, Hong Kong
Novartis Investigative Site, Osaka 560-0005, Japan
Novartis Investigative Site, Saitama 337-0012, Japan
Novartis Investigative Site, Daegu 700-712, Korea, Republic of
Novartis Investigative Site, Daejeon 302-241, Korea, Republic of
Novartis Investigative Site, Incheon 400-711, Korea, Republic of
Novartis Investigative Site, Incheon 403-720, Korea, Republic of
Novartis Investigative Site, Seoul 100-380, Korea, Republic of
Novartis Investigative Site, Seoul 134-727, Korea, Republic of
Novartis Investigative Site, Seoul 135-720, Korea, Republic of
Novartis Investigative Site, Seoul 150-713, Korea, Republic of
Novartis Investigative Site, Seoul 150-950, Korea, Republic of
Novartis Investigative Site, Seoul 152-703, Korea, Republic of
Novartis Investigative Site, Quezon City 1100, Philippines
Novartis Investigative Site, Quezon City 1102, Philippines
Novartis Investigative Site, Valenzuela City 1441, Philippines
Novartis Investigative Site, Changhua 500, Taiwan
Novartis Investigative Site, Kaohsiung 807, Taiwan
Novartis Investigative Site, Taichung 40447, Taiwan
Novartis Investigative Site, Taipei 10002, Taiwan
Novartis Investigative Site, Taipei 114, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Bangkok 10400, Thailand
Novartis Investigative Site, Bangkok 10700, Thailand
Novartis Investigative Site, Chiang Mai 50200, Thailand
Novartis Investigative Site, Chongqing, Chongqing 400042, China
Novartis Investigative Site, Toon-city, Ehime 791-0295, Japan
Novartis Investigative Site, Chikushi-gun, Fukuoka 811-1244, Japan
Novartis Investigative Site, Fukuoka-city, Fukuoka 810-0066, Japan
Novartis Investigative Site, Kitakyushu-city, Fukuoka 807-0856, Japan
Novartis Investigative Site, Bucheon, Gyeonggi-do 424-717, Korea, Republic of
Novartis Investigative Site, Goyang, Gyeonggi-do 412-270, Korea, Republic of
Novartis Investigative Site, Asahikawa, Hokkaido 078-8214, Japan
Novartis Investigative Site, Sapporo-city, Hokkaido 062-0053, Japan
Novartis Investigative Site, Sapporo-city, Hokkaido 063-0842, Japan
Novartis Investigative Site, Sapporo, Hokkaido 003-0026, Japan
Novartis Investigative Site, Sapporo, Hokkaido 003-0825, Japan
Novartis Investigative Site, Changsha, Hunan 410003, China
Novartis Investigative Site, Jeonju-si, Jeollabuk-do 561-712, Korea, Republic of
Novartis Investigative Site, Suzhou, Jiangsu 215006, China
Novartis Investigative Site, Kawasaki-city, Kanagawa 210-0852, Japan
Novartis Investigative Site, Kyotanabe-city, Kyoto 610-0361, Japan
Novartis Investigative Site, Kyoto-city, Kyoto 615-8125, Japan
Novartis Investigative Site, Koyang, Kyunggi 410-719, Korea, Republic of
Novartis Investigative Site, Shenyang, Liaoning 110003, China
Novartis Investigative Site, Quezon City, Manila 1100, Philippines
Novartis Investigative Site, Manila, Metro Manila 1000, Philippines
Novartis Investigative Site, Suita-city, Osaka 565-0871, Japan
Novartis Investigative Site, Toyonaka-city, Osaka 560-0082, Japan
Novartis Investigative Site, Fujimino, Saitama 356-0053, Japan
Novartis Investigative Site, Hiki-Gun, Saitama 355-0328, Japan
Novartis Investigative Site, Koshigaya city, Saitama 343-0826, Japan
Novartis Investigative Site, Tokorozawa-city, Saitama 359-1161, Japan
Novartis Investigative Site, Bundang, Seongnam 463-707, Korea, Republic of
Novartis Investigative Site, Xi'an, Shanxi 710061, China
Novartis Investigative Site, Hong Kong, Shatin, NT, Hong Kong
Novartis Investigative Site, Taichung, Taiwan ROC 40201, Taiwan
Novartis Investigative Site, Taipei, Taiwan, ROC 112, Taiwan
Novartis Investigative Site, Edogawa-ku, Tokyo 133-0061, Japan
Novartis Investigative Site, Edogawa-ku, Tokyo 134-0084, Japan
Novartis Investigative Site, Hachioji-city, Tokyo 192-0918, Japan
Novartis Investigative Site, Hachioji, Tokyo 192-0046, Japan
Novartis Investigative Site, Katsushika-ku, Tokyo 124-0024, Japan
Novartis Investigative Site, Kiyose-city, Tokyo 204-0021, Japan
Novartis Investigative Site, Kunitachi, Tokyo 186-0001, Japan
Novartis Investigative Site, Meguro-ku, Tokyo 152-0031, Japan
Novartis Investigative Site, Minato-ku, Tokyo 105-7390, Japan
Novartis Investigative Site, Minato-ku, Tokyo 108-0075, Japan
Novartis Investigative Site, Shibuya-ku, Tokyo 150-0002, Japan
Novartis Investigative Site, Shinagawa-ku, Tokyo 141-0032, Japan
Novartis Investigative Site, Tachikawa, Tokyo 190-0013, Japan
Novartis Investigative Site, Taito, Tokyo 111-0052, Japan
Novartis Investigative Site, Toshima-ku, Tokyo 171-0021, Japan
Novartis Investigative Site, Hangzhou, Zhejiang 310006, China
Novartis Investigative Site, Hangzhou, Zhejiang 310013, China